Preclinical studies with testosterone implants induced cervical-uterine tumors in mice which metastasized in some cases. Some reports indicate that administration of testosterone cypionate in females can augment the susceptibility to hepatoma as well as increase the number of tumors. Clinical studies have reported cases of hepatocellular carcinoma in long-term high-dose therapy.L1153
Testosterone cypionate is a synthetic derivative of testosterone in the form of an oil-soluble 17 (beta)-cyclopentylpropionate ester. Its benefit compared to other testosterone derivatives is the slow rate of release after injection and longer half-life. It was developed by the company Pharmacia and Upjohn and FDA approved on July 25, 1979.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Aripiprazole | The metabolism of Aripiprazole can be increased when combined with Testosterone cypionate. |
| Aripiprazole lauroxil | The metabolism of Aripiprazole lauroxil can be increased when combined with Testosterone cypionate. |
| Eliglustat | The metabolism of Eliglustat can be decreased when combined with Testosterone cypionate. |
| Ibrutinib | The metabolism of Ibrutinib can be decreased when combined with Testosterone cypionate. |
| Cilostazol | The metabolism of Cilostazol can be decreased when combined with Testosterone cypionate. |
| Colchicine | The metabolism of Colchicine can be decreased when combined with Testosterone cypionate. |
| Fentanyl | Fentanyl may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level. |
| Iloperidone | The metabolism of Iloperidone can be decreased when combined with Testosterone cypionate. |
| Retapamulin | The metabolism of Retapamulin can be decreased when combined with Testosterone cypionate. |
| Tofacitinib | The metabolism of Tofacitinib can be decreased when combined with Testosterone cypionate. |
| Vardenafil | The metabolism of Vardenafil can be decreased when combined with Testosterone cypionate. |
| Zopiclone | The metabolism of Zopiclone can be decreased when combined with Testosterone cypionate. |
| Lovastatin | The metabolism of Lovastatin can be decreased when combined with Testosterone cypionate. |
| Alfuzosin | The metabolism of Alfuzosin can be decreased when combined with Testosterone cypionate. |
| Alprazolam | The metabolism of Alprazolam can be decreased when combined with Testosterone cypionate. |
| Mifepristone | The serum concentration of Testosterone cypionate can be increased when it is combined with Mifepristone. |
| Ifosfamide | The metabolism of Ifosfamide can be increased when combined with Testosterone cypionate. |
| Perampanel | The metabolism of Perampanel can be increased when combined with Testosterone cypionate. |
| Prasterone | The serum concentration of Testosterone cypionate can be increased when it is combined with Prasterone. |
| Warfarin | The serum concentration of Warfarin can be increased when it is combined with Testosterone cypionate. |
| Acenocoumarol | The serum concentration of Acenocoumarol can be increased when it is combined with Testosterone cypionate. |
| (R)-warfarin | The serum concentration of (R)-warfarin can be increased when it is combined with Testosterone cypionate. |
| R,S-Warfarin alcohol | The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Testosterone cypionate. |
| S,R-Warfarin alcohol | The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Testosterone cypionate. |
| (S)-Warfarin | The serum concentration of (S)-Warfarin can be increased when it is combined with Testosterone cypionate. |
| Midazolam | The serum concentration of Midazolam can be increased when it is combined with Testosterone cypionate. |
| Tacrolimus | The serum concentration of Tacrolimus can be increased when it is combined with Testosterone cypionate. |
| Atorvastatin | The metabolism of Atorvastatin can be decreased when combined with Testosterone cypionate. |
| Erlotinib | The serum concentration of Erlotinib can be decreased when it is combined with Testosterone cypionate. |
| Cyclosporine | The risk or severity of liver damage can be increased when Testosterone cypionate is combined with Cyclosporine. |
| Insulin human | Testosterone cypionate may increase the hypoglycemic activities of Insulin human. |
| Insulin lispro | Testosterone cypionate may increase the hypoglycemic activities of Insulin lispro. |
| Insulin glargine | Testosterone cypionate may increase the hypoglycemic activities of Insulin glargine. |
| Insulin pork | Testosterone cypionate may increase the hypoglycemic activities of Insulin pork. |
| Glimepiride | Testosterone cypionate may increase the hypoglycemic activities of Glimepiride. |
| Acetohexamide | Testosterone cypionate may increase the hypoglycemic activities of Acetohexamide. |
| Miglitol | Testosterone cypionate may increase the hypoglycemic activities of Miglitol. |
| Phenformin | Testosterone cypionate may increase the hypoglycemic activities of Phenformin. |
| Gliclazide | Testosterone cypionate may increase the hypoglycemic activities of Gliclazide. |
| Gliquidone | Testosterone cypionate may increase the hypoglycemic activities of Gliquidone. |
| Mitiglinide | Testosterone cypionate may increase the hypoglycemic activities of Mitiglinide. |
| Exenatide | Testosterone cypionate may increase the hypoglycemic activities of Exenatide. |
| Mecasermin | Testosterone cypionate may increase the hypoglycemic activities of Mecasermin. |
| Pramlintide | Testosterone cypionate may increase the hypoglycemic activities of Pramlintide. |
| Glisoxepide | Testosterone cypionate may increase the hypoglycemic activities of Glisoxepide. |
| Insulin aspart | Testosterone cypionate may increase the hypoglycemic activities of Insulin aspart. |
| Insulin detemir | Testosterone cypionate may increase the hypoglycemic activities of Insulin detemir. |
| Insulin glulisine | Testosterone cypionate may increase the hypoglycemic activities of Insulin glulisine. |
| Glymidine | Testosterone cypionate may increase the hypoglycemic activities of Glymidine. |
| AICA ribonucleotide | Testosterone cypionate may increase the hypoglycemic activities of AICA ribonucleotide. |
| Buformin | Testosterone cypionate may increase the hypoglycemic activities of Buformin. |
| Vildagliptin | Testosterone cypionate may increase the hypoglycemic activities of Vildagliptin. |
| Voglibose | Testosterone cypionate may increase the hypoglycemic activities of Voglibose. |
| NN344 | Testosterone cypionate may increase the hypoglycemic activities of NN344. |
| AMG-222 | Testosterone cypionate may increase the hypoglycemic activities of AMG-222. |
| Bisegliptin | Testosterone cypionate may increase the hypoglycemic activities of Bisegliptin. |
| Liraglutide | Testosterone cypionate may increase the hypoglycemic activities of Liraglutide. |
| Gosogliptin | Testosterone cypionate may increase the hypoglycemic activities of Gosogliptin. |
| Glibornuride | Testosterone cypionate may increase the hypoglycemic activities of Glibornuride. |
| Benfluorex | Testosterone cypionate may increase the hypoglycemic activities of Benfluorex. |
| Albiglutide | Testosterone cypionate may increase the hypoglycemic activities of Albiglutide. |
| Dulaglutide | Testosterone cypionate may increase the hypoglycemic activities of Dulaglutide. |
| Insulin beef | Testosterone cypionate may increase the hypoglycemic activities of Insulin beef. |
| Insulin degludec | Testosterone cypionate may increase the hypoglycemic activities of Insulin degludec. |
| Insulin peglispro | Testosterone cypionate may increase the hypoglycemic activities of Insulin peglispro. |
| Insulin tregopil | Testosterone cypionate may increase the hypoglycemic activities of Insulin tregopil. |
| Ipragliflozin | Testosterone cypionate may increase the hypoglycemic activities of Ipragliflozin. |
| Dutogliptin | Testosterone cypionate may increase the hypoglycemic activities of Dutogliptin. |
| Allicin | Testosterone cypionate may increase the hypoglycemic activities of Allicin. |
| Tofogliflozin | Testosterone cypionate may increase the hypoglycemic activities of Tofogliflozin. |
| 2,4-thiazolidinedione | Testosterone cypionate may increase the hypoglycemic activities of 2,4-thiazolidinedione. |
| Teneligliptin | Testosterone cypionate may increase the hypoglycemic activities of Teneligliptin. |
| Omarigliptin | Testosterone cypionate may increase the hypoglycemic activities of Omarigliptin. |
| Carmegliptin | Testosterone cypionate may increase the hypoglycemic activities of Carmegliptin. |
| Gemigliptin | Testosterone cypionate may increase the hypoglycemic activities of Gemigliptin. |
| Anagliptin | Testosterone cypionate may increase the hypoglycemic activities of Anagliptin. |
| Evogliptin | Testosterone cypionate may increase the hypoglycemic activities of Evogliptin. |
| Sotagliflozin | Sotagliflozin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level. |
| Remogliflozin etabonate | Testosterone cypionate may increase the hypoglycemic activities of Remogliflozin etabonate. |
| Carbutamide | Testosterone cypionate may increase the hypoglycemic activities of Carbutamide. |
| Guar gum | Testosterone cypionate may increase the hypoglycemic activities of Guar gum. |
| Metahexamide | Testosterone cypionate may increase the hypoglycemic activities of Metahexamide. |
| Semaglutide | Testosterone cypionate may increase the hypoglycemic activities of Semaglutide. |
| Taspoglutide | Testosterone cypionate may increase the hypoglycemic activities of Taspoglutide. |
| Englitazone | Testosterone cypionate may increase the hypoglycemic activities of Englitazone. |
| Tirzepatide | Testosterone cypionate may increase the hypoglycemic activities of Tirzepatide. |
| Gastric inhibitory polypeptide | Testosterone cypionate may increase the hypoglycemic activities of Gastric inhibitory polypeptide. |
| Bromocriptine | Testosterone cypionate may increase the hypoglycemic activities of Bromocriptine. |
| Empagliflozin | Testosterone cypionate may increase the hypoglycemic activities of Empagliflozin. |
| Acarbose | Testosterone cypionate may increase the hypoglycemic activities of Acarbose. |
| Fluvoxamine | The metabolism of Testosterone cypionate can be decreased when combined with Fluvoxamine. |
| Fluoxetine | The metabolism of Testosterone cypionate can be decreased when combined with Fluoxetine. |
| Nabilone | The metabolism of Testosterone cypionate can be decreased when combined with Nabilone. |
| Felbamate | The metabolism of Testosterone cypionate can be decreased when combined with Felbamate. |
| Sulfinpyrazone | The metabolism of Testosterone cypionate can be decreased when combined with Sulfinpyrazone. |
| Iproniazid | The metabolism of Testosterone cypionate can be decreased when combined with Iproniazid. |
| Medical Cannabis | The metabolism of Testosterone cypionate can be decreased when combined with Medical Cannabis. |
| Troglitazone | The metabolism of Testosterone cypionate can be decreased when combined with Troglitazone. |
| Imatinib | The metabolism of Testosterone cypionate can be decreased when combined with Imatinib. |
| Abiraterone | The metabolism of Testosterone cypionate can be decreased when combined with Abiraterone. |